Table 1.
Participant characteristics, N=399.
| % (n) | Mean (SD) | Range | |
|---|---|---|---|
| Demographics | |||
| Male | 53.1% (212) | ||
| Race | |||
| White | 32.3% (129) | ||
| Black/African American | 23.1% (92) | ||
| Other | 44.6% (178) | ||
| Hispanic ethnicity | 51.4% (205) | ||
| High school degree or greater | 64.2% (256) | ||
| Age | 61.1 years (12.6) | 27–95 years | |
| Hospital Assessment | |||
| Perceived life threat and personal vulnerability total score in the ED | 24.96 (6.89) | 12–46 | |
| Confirmed ACS upon discharge | 34.1% (136) | ||
| One-month Follow-up Assessment | |||
| PTSD total severity scorea | 24.30 (10.33) | 17–76 | |
| Positive screen for probable PTSDb | 15.8% (63) | ||
| Aspirin recommended by doctor | 71.4% (285) | ||
| Reported 100% adherence to aspirin in the past monthc | 85.6% (244) | ||
Note. ED = emergency department. ACS = acute coronary syndrome.
a
PTSD total severity score calculated by summing responses on the PTSD Checklist for a Specific Stressful Experience (PCL-S).
b
Positive screen based on a cut-off of total PCL-S scores greater than or equal to 35.
c
Percentage is for those participants who reported that their doctor recommended aspirin.